Oncology Partnering Terms and Agreements Report
Albany, NY (PRWEB) January 19, 2015 -- The report discusses the structure of oncology partnering agreements, the trends in oncology partnering deals, the most attractive oncology deal-makers, the oncology partnering contract documents, and the top oncology deals by value. The report explores the factors that determine the reasons why greater numbers of companies these days are entering various oncology partnering deals. As per this report, most of the deals are at the development or the discovery stage wherein a licensee receives an option right for licensing the licensor's oncology technology. These oncology partnering deals generally tend to be multi-component since these include the commercialization of outcomes, and mostly start with collaborative research and development.
Request a sample of report at: http://researchmoz.com/enquiry.php?type=sample&repid=93026
This research study provides a detailed analysis of the trends in oncology deal making since the year 2009, thereby covering trends on the basis of the stage of development, the year, the type of technology, therapeutic indications, and the types of deals. Furthermore, the report includes a detailed analysis of the terms of the financial deals, which also includes the distribution of values and the median values for each phase of development. The report also reviews the top ranking oncology deals since 2009.
This research provides a comprehensive overview of the partnering resource center and discusses points like partnering events, online partnering, and includes useful insights into the very concept of deal making. The quantitative and qualitative data included in the report give a clear understanding of the dynamics, the structure, and the ongoing trends in oncology partnering terms and agreements.
Browse report with table of contents at: http://www.researchmoz.us/oncology-partnering-terms-and-agreements-report.html
The report covers the analysis of the actual contract agreements which as a result enables one to assess points like the exact oncology rights that are granted, the resolution of disputes, the type of exclusivity that is granted, the ones who are responsible for commercialization, manufacturing, supply, and development. This research study provides access to headline, upfront, royalty, and milestone data.
Contact Us:
Email: sales(at)researchmoz(dot)us
Michelle Thoras, ResearchMoz, http://www.researchmoz.us/, +1-518-618-1030, [email protected]
Share this article